Exact Sciences (EXAS) Tops Q2 EPS by 12c, Updates Guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
CCEL, SLP, TMQ, More
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $811.1 million versus the consensus estimate of $773.8 million.
GUIDANCE:
Exact Sciences sees FY2025 revenue of $3.13-3.17 billion, versus the consensus of $3.1 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Day 7 ALJ Hearing: Prominent Pain Physician Calls State Medical Marijuana System a Ruse
- Fubo names former Disney+ president Alisa Bowen as new CEO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
